BUDS WITH BENEFITS
Cannabidiol (CBD) oil comes from the Cannabis plant and has become a popular alternative therapy for a range of conditions over the past few years. People report using CBD oil to help reduce pain, anxiety, and sleep disorders.
Cannabidiol (CBD) is a natural compound derived from the cannabis plant. Some evidence suggests that CBD oil may be beneficial for skin health and have uses for a variety of skin conditions.
Scientists from the Lambert Initiative have shown that a medically active component of cannabis does not impact driving ability and moderate THC intoxication lasts a few hours, with implications for drug-driving laws and managing medical cannabis.
Cannabidiol (CBD) has recently gained a lot of traction for its many purported mental and physical health benefits. And anecdotal evidence to support these claims is strong. People tout the products for helping with pain, sleep, and even skin conditions.
Have you been following the recent news reporting the benefits of CBD oils for autism? While scientific studies are underway, families report CBD oils can reduce stress for people on the autism spectrum, as well as lessen aggression, self-injurious behaviors, and anxiety surrounding social interactions.
Cannabidiol (CBD) shouldn’t show up on a drug test.
However, many CBD products contain trace amounts of delta-9-tetrahydrocannabinol (THC), marijuana’s main active ingredient.
If enough THC is present, it will show up on a drug test.
This means that in rare cases, using CBD might lead to a positive drug test. It all depends on the product’s quality and composition.
The CBD industry has booming for sometime now with Savills estimating that market could rise to £1bn by 2025. The shelves of major high-street shops are packed with a plethora of products containing CBD including humous, nail polish and face cream. One use for CBD which is popular in North America, but is yet to truly take off in the UK is CBD for dogs. In light of this, Health Canal guest posted this article to give more insight.
When it comes to ending the so-called war on drugs, the pace of change has been slow.
Many parts of the world still pursue the same failed policies of the last six decades, wasting billions on tough law enforcement, criminalisation, and mass incarceration, without having any impact on supply or demand in what is an ever-growing trade in illicit drugs.
Sadly, criminal sanctions still trump reduction of harm and support for those who struggle with drug misuse and addiction.
The notable exception to this has been the growing support for the legalisation and regulation of both recreational and medicinal cannabis.
Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhea, meningitis and legionnaires disease.
The research collaboration between The University of Queensland and Botanix Pharmaceuticals Limited could lead to the first new class of antibiotics for resistant bacteria in 60 years.